(Reuters) - NEW YORK, July 22 - Medical device maker Ev3 Inc.
said on Sunday it would buy FoxHollow Technologies
Inc. for about $780 million in cash and stock to
expand its array of products that combat vascular disease.
The combination is expected to generate net sales of up to
$615 million in 2008. Ev3's cash-and-stock offer of $25.92 for
each share of FoxHollow represents a premium of more than 20
percent, based on 30-day average trading price for FoxHollow
shares.
Read more at Reuters.com Bonds News
said on Sunday it would buy FoxHollow Technologies
Inc. for about $780 million in cash and stock to
expand its array of products that combat vascular disease.
The combination is expected to generate net sales of up to
$615 million in 2008. Ev3's cash-and-stock offer of $25.92 for
each share of FoxHollow represents a premium of more than 20
percent, based on 30-day average trading price for FoxHollow
shares.
Read more at Reuters.com Bonds News
No comments:
Post a Comment